A close-up of the United States flag with visible red and white stripes and white stars on a blue field. Semi-transparent hexagonal shapes overlay parts of the flag.

American Investment

Investing in America’s Future

America’s biopharmaceutical companies are expanding their manufacturing footprint and pioneering innovative research across the United States.

Amgen is driving U.S. manufacturing leadership in central Ohio.

AstraZeneca is expanding their U.S. footprint to power the future of cell therapy in Maryland.

Astellas expands manufacturing footprint in America to fuel gene therapy innovation.

Bristol Myers Squibb is expanding its U.S. manufacturing presence in Indiana to advance cancer innovation.

Gilead boosts U.S. manufacturing capacity to advance next-generation biologics.

Decades of investment in North Carolina’s biopharmaceutical industry has spurred the state’s economy, workforce development and community engagement.

Lilly invests in Virginia to expand U.S. manufacturing and advance next-generation medicines.

Biogen’s continued investment in North Carolina has created a hub for biotech innovation and economic opportunity.

Merck’s new manufacturing facility in Elkton, Virginia builds on a long-standing investment in the region and continued commitment to deliver innovative treatments to patients.

$500 billion in new biopharmaceutical investment will give a $1.2 trillion boost to America’s economy

Explore how PhRMA member companies are investing in new U.S.-based manufacturing and infrastructure, creating jobs and opportunities for Americans, their families and local communities.

Member Investment News

Dark blue-green background with subtle hexagonal patterns scattered throughout. The hexagons are faint and add a textured effect to the otherwise smooth surface.

Our Impact

Every day, our industry works to bring new treatments and cures to Americans and supports America’s biopharmaceutical leadership. These efforts are made possible by smart policies that encourage innovation and investment and deliver positive economic impacts to communities across the United States.

5M

total U.S. jobs supported

1M+

U.S. workers directly employed

350K+

U.S. manufacturing jobs directly supported

$500B

committed from biopharmaceutical companies for future U.S.based manufacturing and infrastructure investments

1.5K+

domestic manufacturing facilities presently located in 48 states and Puerto Rico

5K+

clinical trials sponsored annually

~1M

Americans participating in clinical trials annually

All 50 States,

D.C. and Puerto Rico host clinical trials

Investing in America's Innovators

More than one million U.S. employees at biopharmaceutical companies work every day to research and develop transformative treatments and cures.

Our industry relies on a talented STEM workforce to advance innovation,supporting nearly 111 million students and 183,000 teachers through 37 STEM education programs across the country.

Learn how we’re investing in the next generation

A scientist wearing safety goggles, a face mask, and blue gloves examines a sample through a microscope in a laboratory setting.

Our industry supports America’s biopharmaceutical leadership.

Our industry’s investments and impact are driven by pro-innovation policies. Explore the biopharmaceutical clusters made possible by smart policy. 

A smooth blue gradient background transitioning from light blue at the top to darker blue at the bottom, with a soft diagonal streak of even lighter blue on the right side.

Protecting American Investment and Leadership in Biopharmaceutical Innovation

Robust, pro-innovation policies are critical to maintaining our country’s leadership and supporting patient access to transformative medicines.

Learn how we can preserve and strengthen American innovation

Our Work in Action

To maintain America’s global leadership, we need to support the next generation of innovation in medicine.

View All Case Studies
The image shows the exterior of a Merck building with the company’s logo and name on the facade. Three flags are flying on the roof against a cloudy sky.

Merck Expands Its 85-Year Manufacturing Presence in Virginia

Merck’s new manufacturing facility in Elkton, Virginia builds on a long-standing investment in the region and continued commitment to deliver innovative treatments to patients.

Read case study
The exterior of a building with the Biogen logo and name displayed in blue letters on the wall; industrial equipment and trees are visible in the background.

Biogen Deepens U.S. Manufacturing Footprint to Advance Cutting-Edge Therapies

Biogen’s continued investment in North Carolina has created a hub for biotech innovation and economic opportunity.

Read case study
A worker wearing a hard hat, safety glasses, and a reflective vest uses a laptop outdoors at an industrial site with machinery and smoke in the background.

Investing in America’s Biopharmaceutical Infrastructure Strengthens the Economy and Supports Union Workers

Read how the biopharmaceutical industry is growing America’s manufacturing and R&D capabilities to develop the next generation of treatments.

Read case study
A person stands on stage beside a large screen displaying a map outline of North Carolina, labeled boldly in red with the words "NORTH CAROLINA.

Driving Economic Growth and Opportunity in North Carolina

The biopharmaceutical industry supports millions of jobs and generates significant economic growth in communities across America.

Read case study
A modern building with large glass windows and vertical brown panels, set on a landscaped street with a bench, small trees, and clear blue sky in the background.

AstraZeneca Invests in the U.S. to Power the Future of Cell Therapy

AstraZeneca’s investment in Maryland creates high-quality jobs and advances next-generation cancer treatments.

Read case study
A person wearing blue gloves and a white lab coat is handling small glass vials filled with clear liquid, arranging them on a reflective metal surface in a laboratory setting.

Vaccines Protect Health and Save Costs

Learn more about how vaccines have a long track record of protecting patient health and providing cost savings.

Read case study
Back to top

Sign up for email updates